Saha, P; Sandhu, V; Robinson, H; Ezeonyeji, A; Al-Shakarchi, I; Chander, S; Suresh, R; Kaul, A; Sofat, N
(2020)
Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience.
In: British Society for Rheumatology Annual Conference 2020, RHEUMATOLOGY.
SGUL Authors: Sofat, Nidhi
![]() |
Microsoft Word (.docx)
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (22kB) |
Official URL: https://doi.org/10.1093/rheumatology/keaa111.179
Item Type: | Conference or Workshop Item (UNSPECIFIED) | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Pratyasha Saha, Virinderjit Sandhu, Helena Robinson, Amara Ezeonyeji, Israa Al-Shakarchi, Sumeet Chander, Resmy Suresh, Arvind Kaul, Nidhi Sofat, P184 Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience, Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.179 is available online at: https://doi.org/10.1093/rheumatology/keaa111.179 | ||||||
Keywords: | Arthritis & Rheumatology, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | ||||||
Journal or Publication Title: | RHEUMATOLOGY | ||||||
Article Number: | keaa111.179 | ||||||
ISSN: | 1462-0324 | ||||||
Dates: |
|
||||||
Publisher License: | Publisher's own licence | ||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/111884 | ||||||
Publisher's version: | https://doi.org/10.1093/rheumatology/keaa111.179 |
Statistics
Item downloaded times since 21 Apr 2020.
Actions (login required)
![]() |
Edit Item |